Calahealth.com Website Review

cala health is a medical technology company pioneering a new clas* of electrical medicine called neuroperipheral therapy. neuroperipheral therapy has the potential to address chronic disease by externally stimulating peripheral nerves with body-worn electronics. cala health is bringing together experts in neuroscience, consumer electronics, and medical devices to develop accessible therapies that treat chronic. cala health receives fda clearance for cala one, a neuroperipheral therapy for essential tremor. american academy of neurology 2018 emerging science program: non-invasive peripheral nerve stimulation for symptomatic relief of. noninvasive neuromodulation in essential tremor demonstrates relief in a sham-controlled pilot trial. exponential medicine 2017: delivering electricity as medicine. cala health's ceo kate rosenbluth selected as a hive innovator for 2017 by tedmed. essential tremor (et) is a common movement disorder affecting over 7 million americans and millions more worldwide. the condition is marked by hand tremors that make it difficult, if not impossible, to perform daily activities like eating, drinking, and writing. cala health is working on a solution that retunes the nervous system in order to relieve the symptoms of et. cala health is striving to put patients in control of their tremor — without the need for invasive brain surgery or drugs. cala health supports the international essential tremor foundation (ietf) and works to connect people living with essential tremor to new therapies. for more information about kate rosenbluth co-founded cala health with scott delp phd and serena wong phd. she has developed cutting-edge neurotherapies with brainlab, autonomic technologies, and genentech. she was a lecturer and fellow in stanford technology ventures program and biodesign and a postdoctoral fellow in ucsf neurosurgery. kate has authored more than 50 patents and peer-reviewed publications. kristie burns has held strategic marketing leadership and business development roles with medical device and biotechnology leaders,